Outcomes With 5-Fluorouracil, Doxorubicin, and Streptozocin (FAS) and Subsequent Therapies in Patients With Well Differentiated Pancreatic Neuroendocrine Tumors (PanNETs)

被引：0
|
作者：
Lam, Michael [1 ]
Rogers, Jane [1 ]
Halperin, Daniel [1 ]
Dagohoy, Cecile [1 ]
Yao, James [1 ]
Dasari, Arvind [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
PANCREAS | 2019年 / 48卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：443 / 444
页数：2
相关论文
共 50 条
  • [21] Epigenetic Dysregulation of 5-hydroxymethylcytosine in Well-Differentiated Pancreatic Neuroendocrine Tumors
    Sharma, Aarti E.
    Olivas, Andrea
    Parilla, Megan
    Yassan, Lindsay
    Wang, Hanlin
    Zhang, Sharon S.
    Weber, Christopher
    Keutgen, Xavier M.
    Hart, John
    Krausz, Thomas
    Setia, Namrata
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022, 30 (02) : E11 - E15
  • [22] Oxaliplatin and 5-fluorouracil (FOLFOX) in advanced well differentiated digestive neuroendocrine tumors: a multicenter national retrospective study from the French Group of Endocrine Tumors (GTE)
    Girot, Paul
    Baudin, Eric
    Senellart, Helene
    Bouarioua, Nadia
    Hentic, Olivia
    Guimbaud, Rosine
    Walter, Thomas
    Ferru, Aurelie
    Roquin, Guillaume
    Cadiot, Guillaume
    Pracht, Marc
    Girot, Jean-Baptiste
    Malka, David
    Ducreux, Michel
    Bennouna, Jaafar
    Matysiak-Budnik, Tamara
    Hadoux, Julien
    Touchefeu, Yann
    NEUROENDOCRINOLOGY, 2022, 112 (06) : 537 - 546
  • [23] Oxaliplatin and 5-Fluorouracil (FOLFOX) in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A National Retrospective Study from the French Group of Endocrine Tumors (GTE)
    Girot, P.
    Baudin, E.
    Senellart, H.
    Bouarioua, N.
    Hentic, O.
    Guimbaud, R.
    Ferru, A.
    Roquin, G.
    Cadiot, G.
    Hadoux, J.
    Matysiak-Budnik, T.
    Touchefeu, Y.
    NEUROENDOCRINOLOGY, 2019, 108 : 150 - 150
  • [24] The Efficacy and Safety of Sunitinib in Patients With Advanced Well-differentiated Pancreatic Neuroendocrine Tumors
    Raymond, Eric
    Kulke, Matthew
    Qin, Shukui
    Schenker, Michael
    Cubillo, Antonio
    Lou, Wenhui
    Tomasek, Jiri
    Thiis-Evensen, Espen
    Xu, Jianming
    Racz, Karoly
    Croitoru, Adina
    Khasraw, Mustafa
    Sedlackova, Eva
    Borbath, Ivan
    Ruff, Paul
    Oberstein, Paul
    Ito, Tetsuhide
    Fernandez, Kathrine
    Rosbrook, Brad
    Fazio, Nicola
    PANCREAS, 2017, 46 (03) : 435 - 435
  • [25] The Efficacy and Safety of Sunitinib in Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (12) : 10 - 11
  • [26] BRAF mutations in patients with well-differentiated pancreatic neuroendocrine tumors (WD pNETs)
    Raj, Nitya Prabhakar
    Meyers, Paul A.
    Saltz, Leonard
    Reidy, Diane Lauren
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [27] Oxaliplatin and 5-fluorouracil (FOLFOX) in advanced well-differentiated digestive neuroendocrine tumors: A multicenter national retrospective study from the French Group of Endocrine Tumors (GTE).
    Girot, Paul
    Baudin, Eric
    Senellart, Helene
    Bouarioua, Nadia
    Hentic, Olivia
    Guimbaud, Rosine
    Walter, Thomas
    Ferru, Aurelie
    Roquin, Guillaume
    Cadiot, Guillaume
    Pracht, Marc
    Girot, Jean-Baptiste
    Malka, David
    Ducreux, Michel
    Hadoux, Julien
    Matysiak-Budnik, Tamara
    Touchefeu, Yann
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [28] Well-differentiated bronchial neuroendocrine tumors: Clinical management and outcomes in 105 patients
    Pericleous, Marinos
    Karpathakis, Anna
    Toumpanakis, Christos
    Lumgair, Heather
    Reiner, Jonathan
    Marelli, Laura
    Thirlwell, Christina
    Caplin, Martyn E.
    CLINICAL RESPIRATORY JOURNAL, 2018, 12 (03): : 904 - 914
  • [29] Increased (>20%) Ki67 Proliferation Index in Morphologically Well Differentiated Pancreatic Neuroendocrine Tumors (PanNETs) Correlates with Decreased Overall Survival
    Basturk, O.
    Yang, Z.
    Tang, L. H.
    Hruban, R.
    McCall, C.
    Adsay, V.
    Krasinskas, A.
    Jang, K-T
    Bellizzi, A.
    Shi, C.
    Klimstra, D. S.
    LABORATORY INVESTIGATION, 2013, 93 : 423A - 423A
  • [30] Increased (>20%) Ki67 Proliferation Index in Morphologically Well Differentiated Pancreatic Neuroendocrine Tumors (PanNETs) Correlates with Decreased Overall Survival
    Basturk, O.
    Yang, Z.
    Tang, L. H.
    Hruban, R.
    McCall, C.
    Adsay, V.
    Krasinskas, A.
    Jang, K-T
    Bellizzi, A.
    Shi, C.
    Klimstra, D. S.
    MODERN PATHOLOGY, 2013, 26 : 423A - 423A
12345